Cargando…
The cell cycle as a brake for β-cell regeneration from embryonic stem cells
The generation of insulin-producing β cells from stem cells in vitro provides a promising source of cells for cell transplantation therapy in diabetes. However, insulin-producing cells generated from human stem cells show deficiency in many functional characteristics compared with pancreatic β cells...
Autores principales: | El-Badawy, Ahmed, El-Badri, Nagwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711007/ https://www.ncbi.nlm.nih.gov/pubmed/26759123 http://dx.doi.org/10.1186/s13287-015-0274-z |
Ejemplares similares
-
Clinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: A Meta-Analysis
por: El-Badawy, Ahmed, et al.
Publicado: (2016) -
Cancer cell-soluble factors reprogram mesenchymal stromal cells to slow cycling, chemoresistant cells with a more stem-like state
por: El-Badawy, Ahmed, et al.
Publicado: (2017) -
Regulators of pluripotency and their implications in regenerative medicine
por: El-Badawy, Ahmed, et al.
Publicado: (2015) -
Mesenchymal Stem Cell Therapy in Diabetes Mellitus: Progress and Challenges
por: El-Badri, Nagwa, et al.
Publicado: (2013) -
MYC Oncogene Contributions to Release of Cell Cycle Brakes
por: García-Gutiérrez, Lucía, et al.
Publicado: (2019)